Saturday, July 11, 2026

pharma · Chronic Hepatitis Delta Virus Infection · Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Huahui Health

Huahui Health drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Changping, CN HQ
3 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Changping, CN
Employees
3
Programs
2
Drugs
2
Patents
0
Intelligence · Drug Pipeline

Huahui Health pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Huahui Health drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to Huahui Health in public FDA and regional records.